First Trust Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-138,550
| Closed | -$22.9M | – | 2713 |
|
|
2021
Q2 | $22.9M | Sell |
138,550
-10,746
| -7% | -$1.79M | 0.02% | 722 |
|
|
2021
Q1 | $22.9M | Buy |
149,296
+73,911
| +98% | +$10M | 0.03% | 666 |
|
|
2020
Q4 | $9.46M | Sell |
75,385
-4,003
| -5% | -$448K | 0.01% | 851 |
|
|
2020
Q3 | $8.05M | Sell |
79,388
-4,203
| -5% | -$429K | 0.01% | 815 |
|
|
2020
Q2 | $8.13M | Sell |
83,591
-138,592
| -62% | -$12.9M | 0.01% | 805 |
|
|
2020
Q1 | $18.4M | Buy |
222,183
+167,898
| +309% | +$16.4M | 0.04% | 504 |
|
|
2019
Q4 | $6.03M | Sell |
54,285
-9,243
| -15% | -$951K | 0.01% | 1021 |
|
|
2019
Q3 | $6.3M | Sell |
63,528
-224,616
| -78% | -$22.3M | 0.01% | 971 |
|
|
2019
Q2 | $28.6M | Sell |
288,144
-145,302
| -34% | -$13.9M | 0.05% | 456 |
|
|
2019
Q1 | $47.8M | Sell |
433,446
-171,785
| -28% | -$18M | 0.1% | 272 |
|
|
2018
Q4 | $55.7M | Buy |
605,231
+271,334
| +81% | +$27.5M | 0.13% | 184 |
|
|
2018
Q3 | $36.8M | Buy |
333,897
+235,890
| +241% | +$24.6M | 0.07% | 340 |
|
|
2018
Q2 | $9.15M | Sell |
98,007
-10,811
| -10% | -$931K | 0.02% | 828 |
|
|
2018
Q1 | $9.03M | Buy |
108,818
+23,253
| +27% | +$2.07M | 0.02% | 798 |
|
|
2017
Q4 | $7.79M | Sell |
85,565
-9,425
| -10% | -$784K | 0.02% | 856 |
|
|
2017
Q3 | $7.24M | Sell |
94,990
-5,409
| -5% | -$409K | 0.02% | 892 |
|
|
2017
Q2 | $7.53M | Buy |
100,399
+17,519
| +21% | +$1.21M | 0.02% | 867 |
|
|
2017
Q1 | $5.41M | Sell |
82,880
-10,806
| -12% | -$636K | 0.02% | 1015 |
|
|
2016
Q4 | $5.16M | Buy |
93,686
+31,482
| +51% | +$1.73M | 0.02% | 993 |
|
|
2016
Q3 | $3.52M | Sell |
62,204
-25,003
| -29% | -$1.23M | 0.01% | 1095 |
|
|
2016
Q2 | $3.64M | Buy |
87,207
+54,788
| +169% | +$2.52M | 0.01% | 1036 |
|
|
2016
Q1 | $1.39M | Sell |
32,419
-21,780
| -40% | -$920K | ﹤0.01% | 1503 |
|
|
2015
Q4 | $2.45M | Buy |
54,199
+10,780
| +25% | +$453K | 0.01% | 1283 |
|
|
2015
Q3 | $1.69M | Buy |
43,419
+3,361
| +8% | +$135K | ﹤0.01% | 1474 |
|
|
2015
Q2 | $1.46M | Buy |
40,058
+8,289
| +26% | +$262K | ﹤0.01% | 1661 |
|
|
2015
Q1 | $916K | Sell |
31,769
-40
| -0.1% | -$1.12K | ﹤0.01% | 1786 |
|
|
2014
Q4 | $770K | Buy |
+31,809
| New | +$717K | ﹤0.01% | 1824 |
|
Other funds holding PRAH
First Trust Advisors's PRAH Position: Q3 2021 in Review
First Trust Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 138,550 shares — an estimated $22.9M sold.
First Trust Advisors first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $55.7M in Q4 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- First Trust Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- First Trust Advisors sold 138,550 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $22.9M.
- First Trust Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- First Trust Advisors's PRA Health Sciences, Inc. position peaked at $55.7M in Q4 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.